Issues in clinical trial design

0Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Many treatments in SSc were thought to be effective until subjected to a well-designed randomized trial. Relying on case reports may be misleading due to publication or reporting bias, selection bias, and lack of a control group. Furthermore, treatment that is not blinded is prone to an unconscious bias to a perception of response by both the investigator and patients.

Cite

CITATION STYLE

APA

Kafaja, S., Furst, D. E., & Pope, J. E. (2012). Issues in clinical trial design. In Scleroderma: From Pathogenesis to Comprehensive Management (pp. 651–660). Springer US. https://doi.org/10.1007/978-1-4419-5774-0_54

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free